Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: A dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients

Otology and Neurotology

Volumn 28, Issue 2, 2007, Pages 157-170

  Klemm, Eckart ^a   Bepperling, Frank ^b   Burschka, Martin A ^c   Mösges, Ralph ^d  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^b Fresenius Kabi Deutschland GmbH   (Germany)

^c Data Analysis and Medical Writing   (Germany)

^d Institut fur Medizinische Statistik   (Germany)

Author keywords

Hemodilution; Hydroxyethyl starch 130 0.4; Idiopathic sudden sensorineural hearing loss

Indexed keywords

GLUCOSE; HETASTARCH; PLACEBO;

ACUTE IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS; ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; FEMALE; HEMODILUTION; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCEPTION DEAFNESS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AUDITORY THRESHOLD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HEARING LOSS, UNILATERAL; HEMODILUTION; HETASTARCH; HUMANS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; SEVERITY OF ILLNESS INDEX;

EID: 33846602310     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000231502.54157.ad     Document Type: Article

References (50)

1. De Kleyn A. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol 1944;32:407-29.
2. Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: Prognosis and incidence. Laryngoscope 1977;87:817-25.
3. Hughes GB, Freedman MA, Haberkamp TJ, Guay ME. Sudden sensorineural hearing loss. Otolaryngol Clin North Am 1996;29: 393-405.
4. Ahmed I, Fenton JE, Manning K, Keogh P. Management of sudden sensorineural hearing loss-A national survey. Ir Med J 2004;97:146-7.
5. Baujat B, De Minteguiaga C, Lecanu JB, Herman P, Tran Ba Huy P. Is sudden sensorineural hearing loss a therapeutic emergency? Early results in a prospective cohort of 136 patients. Ann Otolaryngol Chir Cervicofac 2002;119:3-11.
6. Klemm E. Initiation of therapy and type of therapy in sudden deafness: An observation including the medico-legal viewpoint. Laryngorhinootologie 1991;70:359-61. [English abstr].
7. Probst R. Sudden deafness. Ther Umsch 1993;50:641-6. [English abstr].
8. Schuknecht HF, Donovan ED. The pathology of idiopathic sudden sensorineural hearing loss. Arch Otorhinolaryngol 1986;243:1-15.
9. Schuknecht HF. Myths in neurotology. Am J Otol 1992;13:124-6.
10. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-80.
11. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772-6.
12. Laird N, Wilson WR. Predicting recovery from idiopathic sudden hearing loss. Am J Otolaryngol 1983;4:161-4.
13. Probst R, Tschopp K, Ludin E, Kellerhals B, Podvinec M, Pfaltz CR. A randomized, double-blind, placebo-controlled study of dextran-pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol 1992;112:435-43.
14. Guyot JP, Thielen K. Evolution of sudden deafness without treatment. Schweiz Med Wochenschr 2000;116:S9-6.
15. Weinaug P. Spontaneous remission in sudden deafness. HNO 1984;32:346-51. [English abstr].
16. Heiden C, Porzsolt F, Biesinger E, Höing R. Spontaneous remission of sudden deafness. HNO 2000;48:621-3. [German].
17. Heiden C, Biesinger E, Höring R, Porzsolt F. Die Spontanheilung des Hörsturzes, eine Metaanalyse der Literatur. HNO Inf 2000;24: 105. [German].
18. Leong HK, Loh KK. Prognostic factors in idiopathic sudden hearing loss. Ann Acad Med Singapore 1991;20:624-7.
19. Ogasawara H, Morimoto K, Ishii K, Sohma S, Asakura K, Kataura A. A statistical analysis of sudden deafness. Nippon Jibiinkoka Gakkai Kaiho 1993;96:914-21.
20. Michel O, Jahns T, Joost-Enneking M, Neugebauer P, Streppel M, Stennert E. The Stennert antiphlogistic-rheologic infusion scheme in treatment of cochleovestibular disorders. HNO 2000;48:182-8. [English abstr].
21. Suckfüll M, Thiery J, Wimmer C, Mees K, Schorn K. Hypercholesteremia and hyperfibrinogenemia in sudden deafness. Laryngorhinootologie 1997;76:453-7. [English abstr].
22. Klemm E, Holotiuk K. Kriterien der Hämorheologie. HNO Heute 1997;2:94-7. [German].
23. Holotiuk K, Ernst F. Bestimmung ausgewählter hämorheologischer Parameter bei Patienten mit Hörsturz und Vestibularisausfall. Perfusion 1997;10:433-8. [German].
24. Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 1994;114:601-7.
25. Ehrly AM, Landgraf H, Moschner PV, Saeger-Lorenz K. Behavior of tissue oxygen pressure and flow properties of blood in patients with intermittent claudication following infusion of 500 ml of a 6% hydroxyethyl starch solution in comparison to physiologic saline solution. Vasa 1987;16:103-13. [English abstr].
26. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 1994;13:301-10. [English abstr].
27. Boldt J, Ducke M, Kumle B, Papsdorf M, Zurmeyer E. Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intensive Care Med 2004;30:416-22.
28. Cadoni G, Fetoni AR, Agostino S, et al. Autoimmunity in sudden sensorineural hearing loss: Possible role of anti-endothelial cell autoantibodies. Acta Otolaryngol 2002:S30-3.
29. Waitzinger J, Bepperling F, Pabst G, Opitz J, Müller M, Baron J. Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification (HES (130/0.4)) after single-dose infusion of 6% or 10% solutions in healthy volunteers. Clin Drug Invest 1998;16:151-60.
30. Waitzinger J, Bepperling F, Pabst G, Opitz J. Hydroxyethyl starch (HES) 130/0.4, a new HES specification: Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D 2003;4:149-57.
31. Leunig A, Szeimies RM, Wilmes E, Gutmann R, Stolz W, Feyh J. Clinical and electron microscopy study of sudden deafness treatment with the 10% HES 200/0.5 and pentoxifylline combination. Laryngorhinootologie 1995;74:135-40. [English abstr].
32. Jurecka W. Hydroxyl starch-Tissue storage and pruritus. Krankenhauspharmazie 1994:703. [German].
33. Gall H, Kaufmann R, von Ehr M, Schumann K, Sterry W. Persistent pruritus after hydroxyethyl starch infusions. Retrospective long-term study of 266 cases. Hautarzt 1993;44:713-6. [English abstr].
34. Reimann S, Szepfalusi Z, Kraft D, Luger T, Metze D. Hydroxyethyl starch accumulation in the skin with special reference to hydroxyethyl starch-associated pruritus. Dtsch Med Wochenschr 2000;125:280-5. [English abstr].
35. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F. Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D 2003;4:331-8.
36. Friedrich G, Ott E. Prospective randomized study on the comparative effect between 10% HES 200/0.5 and 6% HES 200/0.5 in patients with hearing loss. Laryngorhinootologie 1991;70:670-4. [English abstr].
37. Desloovere C, Meyer-Breiting E, von Ilberg C. Randomized double-blind study of therapy of sudden deafness: Initial results. HNO 1988;36:417-22. [English abstr].
38. Desloovere C, Lörz M, Klima A. Sudden sensorineural hearing loss influence of hemodynamical and hemorheological factors on spontaneous recovery and therapy results. Acta Otorhinolaryngol Belg 1989;43:31-7.
39. Desloovere C, Knecht R. Infusion therapy in sudden deafness. Reducing the risk of pruritus after hydroxyethyl starch and maintaining therapeutic success-A prospective randomized study. Laryngorhinootologie 1995;74:468-72. [German, English abstr].
40. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995;311:485.
41. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline General Considerations for Clinical Trials E8. Available at: http://www.ich.org/LOB/media/ MEDIA484.pdf. Accessed March 1, 2006.
42. German Ministerial Ordinance on GCP. Verordnung über die Anwendung der Guten klinischen Praxis bei der Durchführung von klinischen Prüfungen mit Arzneimitteln zur Anwendung am Menschen. Bundesgesetzblatt 2004;1:2081-91.
43. Sjostrand F, Edsberg L, Hahn RG. Volume kinetics of glucose solutions given by intravenous infusion. Br J Anaesth 2001;87: 834-43.
44. Burschka MA, Hassan HA, Reineke T, van Bebber L, Caird DM, Mosges R. Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients. Eur Arch Otorhinolaryngol 2001;258:213-9.
45. Harada T. Patterns of hearing recovery in idiopathic sudden sensorineural hearing loss. Br J Audiol 1996;30:363-7.
46. Hernandez AV, Steyerberg EW, Habbema JDF. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol 2004;57:454-60.
47. Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. Am J Otol 1999;20:587-95.
48. Halpin C, Rauch SD. Using audiometric thresholds and word recognition in a treatment study. Otol Neurotol 2006;27:110-6.
49. Suckfüll M, Winkler G, Thein E, Raab S, Schorn K, Mees K. Changes in serum osmolarity influence the function of outer hair cells. Acta Otolaryngol 1999;119:316-21.
50. Ganzer U. Leitlinie Hörsturz, Konsensusbericht der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde Kopf- und Hals-Chirurgie. HNO Inf 2004;29:302-9.